Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer stemness, intratumoral heterogeneity, and immune response across cancers
Alex Miranda, Phineas T. Hamilton, Allen W. Zhang, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 18, pp. 9020-9029
Open Access | Times Cited: 453

Showing 1-25 of 453 citing articles:

Cancer stem cell–immune cell crosstalk in tumour progression
Defne Bayık, Justin D. Lathia
Nature reviews. Cancer (2021) Vol. 21, Iss. 8, pp. 526-536
Open Access | Times Cited: 382
Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better?
John H. Strickler, Brent A. Hanks, Mustafa Khasraw
Clinical Cancer Research (2020) Vol. 27, Iss. 5, pp. 1236-1241
Open Access | Times Cited: 320
A single-cell atlas of the multicellular ecosystem of primary and metastatic hepatocellular carcinoma
Yiming Lu, Aiqing Yang, Cheng Quan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 249
Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy
Filippo Galli, Jesus Vera Aguilera, Belinda Palermo, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 230
Cancer Stemness Meets Immunity: From Mechanism to Therapy
Peiwen Chen, Wen‐Hao Hsu, Jincheng Han, et al.
Cell Reports (2021) Vol. 34, Iss. 1, pp. 108597-108597
Open Access | Times Cited: 181
Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response
Zhen Zhang, Zixian Wang, Yan‐Xing Chen, et al.
Genome Medicine (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 163
Circadian Regulator CLOCK Recruits Immune-Suppressive Microglia into the GBM Tumor Microenvironment
Peiwen Chen, Wen‐Hao Hsu, Andrew Chang, et al.
Cancer Discovery (2020) Vol. 10, Iss. 3, pp. 371-381
Open Access | Times Cited: 161
Mechanisms of acquired tumor drug resistance
Svetlana N. Aleksakhina, Aniruddh Kashyap, Evgeny N. Imyanitov
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2019) Vol. 1872, Iss. 2, pp. 188310-188310
Closed Access | Times Cited: 157
How cancer cells make and respond to interferon-I
HyeonJoo Cheon, Yuxin Wang, Samantha M. Wightman, et al.
Trends in cancer (2022) Vol. 9, Iss. 1, pp. 83-92
Open Access | Times Cited: 96
Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance
Rongbin Ge, Zongwei Wang, Liang Cheng
npj Precision Oncology (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 95
Pan-cancer landscape of T-cell exhaustion heterogeneity within the tumor microenvironment revealed a progressive roadmap of hierarchical dysfunction associated with prognosis and therapeutic efficacy
Zicheng Zhang, Lu Chen, Jun Chen, et al.
EBioMedicine (2022) Vol. 83, pp. 104207-104207
Open Access | Times Cited: 90
Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer
Hang Zheng, Heshu Liu, Huayu Li, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 75
Tumour immunotherapy: lessons from predator–prey theory
Phineas T. Hamilton, Bradley R. Anholt, Brad H. Nelson
Nature reviews. Immunology (2022) Vol. 22, Iss. 12, pp. 765-775
Closed Access | Times Cited: 73
Hallmarks of cancer stemness
Jia-Jian Loh, Stephanie Ma
Cell stem cell (2024) Vol. 31, Iss. 5, pp. 617-639
Closed Access | Times Cited: 63
Tumor heterogeneity: preclinical models, emerging technologies, and future applications
Marco Proietto, Martina Crippa, C. Damiani, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 56
Genomic and microenvironmental heterogeneity shaping epithelial-to-mesenchymal trajectories in cancer
Guidantonio Malagoli Tagliazucchi, Anna J. Wiecek, Eloise Withnell, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 46
Mapping single-cell developmental potential in health and disease with interpretable deep learning
Minji Kang, José Juan Almagro Armenteros, Gunsagar S. Gulati, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 26
Cancer stem cells and niches: challenges in immunotherapy resistance
Yonglong Pan, Chaoyi Yuan, Chenglong Zeng, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Overcoming cancer therapy resistance: From drug innovation to therapeutics
Jinrui Wei, Meng‐Yi Lu, Tian‐Hua Wei, et al.
Drug Resistance Updates (2025) Vol. 81, pp. 101229-101229
Closed Access | Times Cited: 2
PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?
Mustafa Khasraw, David A. Reardon, Michael Weller, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 20, pp. 5287-5296
Open Access | Times Cited: 110
circFAT1 Promotes Cancer Stemness and Immune Evasion by Promoting STAT3 Activation
Lingfei Jia, Yilun Wang, Cun‐Yu Wang
Advanced Science (2021) Vol. 8, Iss. 13
Open Access | Times Cited: 99
Hypoxia-Driven Effects in Cancer: Characterization, Mechanisms, and Therapeutic Implications
Rachel Shi, Chengheng Liao, Qing Zhang
Cells (2021) Vol. 10, Iss. 3, pp. 678-678
Open Access | Times Cited: 96
Context-Dependent Glioblastoma–Macrophage/Microglia Symbiosis and Associated Mechanisms
Wenjing Xuan, Maciej S. Lesniak, C. David James, et al.
Trends in Immunology (2021) Vol. 42, Iss. 4, pp. 280-292
Open Access | Times Cited: 87
An algorithm to quantify intratumor heterogeneity based on alterations of gene expression profiles
Mengyuan Li, Zhilan Zhang, Lin Li, et al.
Communications Biology (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 79
A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression
Jing Liu, Daniela Ottaviani, Meriem Sefta, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 78
Page 1 - Next Page

Scroll to top